Background: Off-pump coronary artery bypass surgery should have a significantly lower risk of postoperated bleeding than on-pump surgery. However, the use of a cell saver has been considered necessary, with significant additional cost incurred. Can we consider performing off-pump coronary artery bypass surgery without a cell saver?
Patients and methods: A prospective observational study was performed in 68 consecutive patients operated on for 2- or 3-vessel coronary lesions by the off-pump technique.
Results: The mean number of distal anastomoses was 2.7 ± 0.7. Both internal thoracic arteries were used in 45 patients, and sequential revascularization was performed in 27, with 140 (77.8%) arterial grafts. Cell savers were used in 21 (30.9%) patients. In these 21 patients, the mean volume retransfused after treatment was 315 ± 177 mL. Postoperatively, 11 (16.2%) patients were transfused with packed red blood cells, with a mean volume of 636 ± 234 mL per patient. The 2 factors identified as associated with a higher risk of autotransfusion were female sex and a lower preoperative hemoglobin.
Conclusions: The use of a cell saver in off-pump surgery is useless in most cases. Careful surgical hemostasis is essential to limit hypovolemia.
KussOvon SalviatiBBörgermannJ. Off-pump versus on-pump coronary artery bypass grafting: a systematic review and meta-analysis of propensity score analyses. J Thorac Cardiovasc Surg2010; 140: 829–835.
2.
KerendiFMorrisCDPuskasJD. Off-pump coronary bypass surgery for high-risk patients: only in expert centers?Curr Opin Cardiol2008; 23: 573–578.
3.
CorbineauHVerhoyeJPLanganayTMénestretPLeguerrierA. Feasibility of the utilisation of the right internal thoracic artery in the transverse sinus in off pump coronary revascularisation: early angiographic results. Eur J Cardiothorac Surg2001; 20: 918–922.
4.
Shroyer AL, Grover FL, Hattler B, Collins JF, McDonald GO and Kozora E. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med 2009; 361: 1827–1837.
5.
DeFoeGRRossCSOlmsteadEMSurgenorSDFillingerMPGroomRC. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg2001; 71: 769–776.
6.
KarkoutiKDjaianiGBorgerMABeattieWSFedorkoLWijeysunderaD. Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg2005; 80: 1381–1387.
7.
KarkoutiKBeattieWSWijeysunderaDNRaoVChanCDattiloKM. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg2005; 129: 391–400.
8.
HabibRHZachariasASchwannTARiordanCJEngorenMDurhamSJ. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome. Crit Care Med2005; 33: 1749–1756.
9.
KochCGKhandwalaFLiLEstafanousFGLoopFDBlackstoneEH. Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg2006; 82: 13–20.
10.
KochCGLiLDuncanAIMihaljevicTCosgroveDMLoopFD. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med2006; 34: 1608–1616.
11.
KochCGLiLDuncanAIMihaljevicTLoopFDStarrNJ. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg2006; 81: 1650–1657.
12.
KochCGLiLVan WagonerDRDuncanAIGillinovAMBlackstoneEH. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg2006; 82: 1747–1756.
13.
EngorenMCHabibRHZachariasASchwannTARiordanCJDurhamSJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg2002; 74: 1180–1186.
14.
MurphyGJReevesBCRogersCARizviSICullifordLAngeliniGD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation2007; 116: 2544–2552.
15.
NiranjanGAsimakopoulosGKaragounisACockerillGThompsonMChandrasekaranV. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial. Eur J Cardiothorac Surg2006; 30: 271–277.
16.
DamgaardSSteinbrüchelDA. Autotransfusion with cell saver for off-pump coronary artery bypass surgery: a randomized trial. Scand Cardiovasc J2006; 40: 194–198.
17.
GoelPPannuHMohanDAroraR. Efficacy of cell saver in reducing homologous blood transfusions during OPCAB surgery: a prospective randomized trial. Transfus Med2007; 17: 285–289.
18.
DialSDelabaysEAlbertMGonzalezACamardaJLawA. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. J Thorac Cardiovasc Surg2005; 130: 654–661.
